Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127129341 | 12712934 | 1 | I | 20160825 | 20160902 | 20160902 | EXP | US-ASTRAZENECA-2016SE92094 | ASTRAZENECA | 77.00 | YR | F | Y | 0.00000 | 20160902 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127129341 | 12712934 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | FK0154 | 206995 | 250 | MG | TABLET | QD | ||||||
127129341 | 12712934 | 2 | SS | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 0 | TABLET | ||||||||||
127129341 | 12712934 | 3 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
127129341 | 12712934 | 4 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | 0 | ||||||||||||
127129341 | 12712934 | 5 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
127129341 | 12712934 | 6 | C | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127129341 | 12712934 | 1 | Lung carcinoma cell type unspecified stage 0 |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127129341 | 12712934 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127129341 | 12712934 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |